Mary Fisher, Chief Operating Officer at ACORDA THERAPEUTICS INC (ACOR), sold 7,500 shares at $19.41 ($147K) on 2007-06-01, disclosed to the SEC on 2007-06-05.
Scheduled sale ($147k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.40 | 500 | $10K | 6.6% |
| 2 | $19.41 | 1,900 | $37K | 25.1% |
| 3 | $19.45 | 500 | $10K | 6.6% |
| 4 | $19.46 | 500 | $10K | 6.6% |
| 5 | $19.47 | 500 | $10K | 6.6% |
| 6 | $19.48 | 100 |
| $2K |
| 1.3% |
| 7 | $19.52 | 1,000 | $20K | 13.3% |
| 8 | $19.64 | 500 | $10K | 6.7% |
| 9 | $19.77 | 500 | $10K | 6.7% |
| 10 | $19.80 | 17 | $337 | 0.2% |
| 11 | $19.90 | 100 | $2K | 1.4% |
| 12 | $19.99 | 500 | $10K | 6.8% |
| 13 | $20.13 | 883 | $18K | 12.1% |
| Total | $19.61 avg | 7,500 | $147K | 100% |
| Filing → |
| OVAS | BUY | 2015-09-11 | $101K | — | Filing → |
| ZLTQ | SELL | 2015-01-27 | $1.7M | — | Filing → |
| ACOR | SELL | 2007-07-05 | $133K | — | Filing → |